Exact Mass: 614.3335804000001

Exact Mass Matches: 614.3335804000001

Found 255 metabolites which its exact mass value is equals to given mass value 614.3335804000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Neomycin

(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol

C23H46N6O13 (614.3122705999999)

A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed). Neomycin is a bactericidal aminoglycoside antibiotic that binds to the 30S ribosome of susceptible organisms. Binding interferes with mRNA binding and acceptor tRNA sites and results in the production of non-functional or toxic peptides. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AB - Antibiotics S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID N022

Synaptolepis factor K1

C36H54O8 (614.3818484)

Toxiferine

Toxiferine I

C40H46N4O2+2 (614.3620576)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

Harderoporphyrinogen

3-[9,20-bis(2-carboxyethyl)-14-ethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-3,5,9,11(23),14,16(22),18(21),19-octaen-4-yl]propanoic acid

C35H42N4O6 (614.3104192000001)

Harderoporphyrinogen is an intermediate in the conversion of coproporphyrinogen III and protoporphyrinogen IX. An intermediate in the conversion of coproporphyrinogen III and protoporphyrinogen IX. [HMDB]

Neomycin sulfate

5-amino-2-(aminomethyl)-6-({5-[(3,5-diamino-2-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)oxane-3,4-diol

C23H46N6O13 (614.3122705999999)

4-[[(1R)-2-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid

3-({2-[(2-{[(adamantan-2-yloxy)(hydroxy)methylidene]amino}-1-hydroxy-3-(1H-indol-3-yl)-2-methylpropylidene)amino]-1-phenylethyl}-C-hydroxycarbonimidoyl)propanoate

C35H42N4O6 (614.3104192000001)

4-[4-[(2R,5R)-5-[2-(Dibenzylamino)-2-oxoethyl]-2-heptyl-4-oxo-1,3-thiazolidin-3-yl]butyl]benzoic acid

C37H46N2O4S (614.3178116)

PA(8:0/PGJ2)

[(2R)-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}-3-(octanoyloxy)propoxy]phosphonic acid

C31H51O10P (614.3219676)

PA(8:0/PGJ2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/PGJ2), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Prostaglandin J2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGJ2/8:0)

[(2R)-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}-2-(octanoyloxy)propoxy]phosphonic acid

C31H51O10P (614.3219676)

PA(PGJ2/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGJ2/8:0), in particular, consists of one chain of one Prostaglandin J2 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

(4alpha,6alpha,7alpha,17alpha,20S,23R,24E)-2,3,5,6-tetrahydro-7,23,26-trihydroxy-6-p-methoxyphenyl-13,30-cyclo-29-nordammara-2,11,24-trieno[4,3-c]pyran-21-oic acid gamma-lactone|dichapetalin K

C39H50O6 (614.3607199999999)

3beta-hydroxyresiniferonol-6alpha,7alpha-epoxy-9,13,14-ortho-2E-hexadecenoate|synaptolepsis factor K7

C36H54O8 (614.3818484)

3beta,16beta,23-triacetoxyolean-12-en-28-oic acid

C36H54O8 (614.3818484)

C34H46O10

C34H46O10 (614.3090816)

Aristoaristone

C40H46N4O2 (614.3620576)

19S-pleiomutinine|pleiomutinine

C40H46N4O2 (614.3620576)

89200-05-5

C30H46O13 (614.2938266)

kurilensoside H

(25S)-3-O-(beta-D-xylopyranosyl)-4beta,5beta-epoxycholestan-3beta,6beta,8,15alpha,16beta,26-hexol

C32H54O11 (614.3665933999999)

C35H42N4O6

C35H42N4O6 (614.3104192000001)

C40H46N4O2

C40H46N4O2 (614.3620576)

Korksaeure-mono-<3>cinobufotalylester|Korksaeure-mono-[3]cinobufotalylester

C34H46O10 (614.3090816)

O-Acetyldelectin

C33H46N2O9 (614.3203146)

Tri-Ac-(3beta,15alpha,16alpha)-3,15,16-Trihydroxy-12-oleanen-28-oic acid

C36H54O8 (614.3818484)

electrin 4

C30H46N8O6 (614.3540135999999)

C29H47ClN4O8

C29H47ClN4O8 (614.3082252)

(19E,17S,19E)-1-acetyl-17,17-epoxy-(16betaH)-[1,17]bicuranyl-19,19-diene|Isostrychnobilin|isostrychnobiline

C40H46N4O2 (614.3620576)

C33H46N2O9

C33H46N2O9 (614.3203146)

3-O-alpha-L-rhamnopyranosyl-(1<>2)-beta-D-glucopyranosyl-(13E)-labda-8(17),13-diene-3beta,15-diol|3-O-alpha-L-rhamnopyranosyl-(1[]2)-beta-D-glucopyranosyl-(13E)-labda-8(17),13-diene-3beta,15-diol

3-O-alpha-L-rhamnopyranosyl-(1<*>2)-beta-D-glucopyranosyl-(13E)-labda-8(17),13-diene-3beta,15-diol|3-O-alpha-L-rhamnopyranosyl-(1[*]2)-beta-D-glucopyranosyl-(13E)-labda-8(17),13-diene-3beta,15-diol

C32H54O11 (614.3665933999999)

Pleiomutinin

C40H46N4O2 (614.3620576)

15G256epsilon

C31H42N4O9 (614.2951642)

16-ketopetuniasterone A 7-acetate

C34H46O8S (614.2913236)

milbemycin alpha23

C35H50O9 (614.345465)

2beta,3beta-Diacetoxy-Delta12-oleanen-23,28-disaeuredimethylester|2beta,3beta-Diacetoxy-olean-12-en-23,28-disaeure-dimethylester|2beta,3beta-diacetoxy-olean-12-ene-23,28-dioic acid dimethyl ester|2beta,3beta-Diacetoxyolean-12-en-23,28-bissaeure-methylester|acide medicagenique diacetate dimethyl ester|diacetate dimethylester de lacide medicagenique|diacetate du methylester de lacide medicanique

2beta,3beta-Diacetoxy-Delta12-oleanen-23,28-disaeuredimethylester|2beta,3beta-Diacetoxy-olean-12-en-23,28-disaeure-dimethylester|2beta,3beta-diacetoxy-olean-12-ene-23,28-dioic acid dimethyl ester|2beta,3beta-Diacetoxyolean-12-en-23,28-bissaeure-methylester|acide medicagenique diacetate dimethyl ester|diacetate dimethylester de lacide medicagenique|diacetate du methylester de lacide medicanique

C36H54O8 (614.3818484)

Di-O-acetyl-acinosolsaeure-dimethylester

C36H54O8 (614.3818484)

spinosyn alphaa

C35H50O9 (614.345465)

ingol 3,12-diacetate 7,8-ditiglate

C34H46O10 (614.3090816)

C36H54O8

C36H54O8 (614.3818484)

Di-Me ester-Mesobiliverdin IXalpha

C35H42N4O6 (614.3104192000001)

dichrostachine M

C37H42O8 (614.2879532000001)

13beta-ent-3,14-clerodadien 6alpha-O-beta-D-quinovopyranosyl-13-O-beta-D-glucopyranoside

C32H54O11 (614.3665933999999)

C35H50O9

C35H50O9 (614.345465)

(1S,3R,4S,4aR,8aR)-1,2,3,4,4a,5,6,8a-octahydro-4-[(3S)-3-hydroxy-3-methylpent-4-en-1-yl]-3,4,8,8a-tetramethylnaphthalen-1-yl 6-deoxy-4-O-beta-D-glucopyranosyl-alpha-L-mannopyranoside|(6S,13S)-6-{[beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranosyl]oxy}cleroda-3,14-dien-13-ol

(1S,3R,4S,4aR,8aR)-1,2,3,4,4a,5,6,8a-octahydro-4-[(3S)-3-hydroxy-3-methylpent-4-en-1-yl]-3,4,8,8a-tetramethylnaphthalen-1-yl 6-deoxy-4-O-beta-D-glucopyranosyl-alpha-L-mannopyranoside|(6S,13S)-6-{[beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranosyl]oxy}cleroda-3,14-dien-13-ol

C32H54O11 (614.3665933999999)

18-O-alpha-L-rhamnopyranosyl-(1<*>2)-beta-D-glucopyranosyl-13-epitorreferol

C32H54O11 (614.3665933999999)

6alpha,7alpha-epoxy-5beta-hydroxy-9,13,14-ortho-[(2E,4E)-deca-2,4-dien-1-yl]-resiniferonol-12beta-yl butanoate|yuanhualine

C34H46O10 (614.3090816)

1,2-dihydro-5beta-hydroxy-21-methyl-6alpha,7alpha-epoxy-9,13,14-ortho-1alpha-(33E-pentadecenoate)-resiniferonol-36-oic acid|kirkinine B

C36H54O8 (614.3818484)

6-O-sec-hydroxyaeginetoyl ajugol|6-O-seco-hydroxyaeginetoyl ajugol

C30H46O13 (614.2938266)

8,12-O-diacetylingol 3,7-ditiglate

C34H46O10 (614.3090816)

1-O-cinnamoyl-1-O-debenzoylohchinal

C37H42O8 (614.2879532000001)

rehmaglutosides G

C30H46O13 (614.2938266)

HEKVC|His-Glu-Lys-Val-Cys

C25H42N8O8S (614.2846172000001)

rehmaglutosides H

C30H46O13 (614.2938266)

13-propanoylonchidiol

C35H50O9 (614.345465)

bisaristone B

C40H46N4O2 (614.3620576)

Nemadectin alpha2

C36H54O8 (614.3818484)

Ile-Arg-Ala-Gln-Gln

C25H46N10O8 (614.3499916000001)

3-O-beta-D-glucopyranosyl-13-O-alpha-L-rhamnopyranosyl-3beta-hydroxymanool

C32H54O11 (614.3665933999999)

(1S,3R,4S,4aR,8aR)-1,2,3,4,4a,5,6,8a-octahydro-4-[(3E)-5-hydroxy-3-methylpent-3-en-1-yl]-3,4,8,8a-tetramethylnaphthalen-1-yl 6-deoxy-4-O-beta-D-glucopyranosyl-alpha-L-mannopyranoside|(6S,13E)-6-{[beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranosyl]oxy}cleroda-3,13-dien-15-ol

(1S,3R,4S,4aR,8aR)-1,2,3,4,4a,5,6,8a-octahydro-4-[(3E)-5-hydroxy-3-methylpent-3-en-1-yl]-3,4,8,8a-tetramethylnaphthalen-1-yl 6-deoxy-4-O-beta-D-glucopyranosyl-alpha-L-mannopyranoside|(6S,13E)-6-{[beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranosyl]oxy}cleroda-3,13-dien-15-ol

C32H54O11 (614.3665933999999)

3-O-alpha-L-rhamnopyranosyl-(1<*>2)-beta-D-glucopyranosyl-3beta-hydroxy-13-epimanool

C32H54O11 (614.3665933999999)

12xi-acetoxy-11beta-hydroxypetuniasterone M 7-acetate

C35H50O9 (614.345465)

Phyllactone B

C36H54O8 (614.3818484)

16beta-hydroxy-ent-kauran-19-oic acid 19-[alpha-L-arabinopyranosyl-(1->2)-beta-D-glucopyranosyl] ester

C31H50O12 (614.3302100000001)

C27H50O15

C27H50O15 (614.314955)

(6S,13S)-6-O-alpha-L-rhamnopyranosyl-(1<>2)-beta-D-glucopyranosyl-6,13-dihydroxycleroda-3,14-diene|(6S,13S)-6-O-alpha-L-rhamnopyranosyl-(1[]2)-beta-D-glucopyranosyl-6,13-dihydroxycleroda-3,14-diene|(6S,13S)-cleroda-3,14-diene-6,13-diol 6-O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside|alpha-vinyl-1,2,3,4,4a,7,8,8a-octahydro-alpha,1,2,4a,5-pentamethyl-1-naphthalenepropanol 4-O-alpha-rhamnopyranosy-(1-2)-beta-glucopyranoside

(6S,13S)-6-O-alpha-L-rhamnopyranosyl-(1<*>2)-beta-D-glucopyranosyl-6,13-dihydroxycleroda-3,14-diene|(6S,13S)-6-O-alpha-L-rhamnopyranosyl-(1[*]2)-beta-D-glucopyranosyl-6,13-dihydroxycleroda-3,14-diene|(6S,13S)-cleroda-3,14-diene-6,13-diol 6-O-alpha-L-rhamnopyranosyl-(1-2)-beta-D-glucopyranoside|alpha-vinyl-1,2,3,4,4a,7,8,8a-octahydro-alpha,1,2,4a,5-pentamethyl-1-naphthalenepropanol 4-O-alpha-rhamnopyranosy-(1-2)-beta-glucopyranoside

C32H54O11 (614.3665933999999)

petuniasterone L

C34H46O8S (614.2913236)

adociasulfate 7

C36H54O6S (614.3640904)

2alpha,3beta,23-triacetoxyurs-12-ene-28-oic acid|2alpha,3beta,23alpha-Triacetoxy-urs-12-en-28-oic acid|2alpha.3beta.23-triacetoxy-ursen-(12)-oic acid-(28)|2alpha.3beta.23-Triacetoxy-ursen-(12)-saeure-(28)|asiatic acid triacetate|triacetylasiatic acid

C36H54O8 (614.3818484)

gambogic acid

C37H42O8 (614.2879532000001)

Di-Me ester-Mesobiliverdin IIIalpha

C35H42N4O6 (614.3104192000001)

blastmycetin A

C35H46N6O4 (614.3580356)

bisaristone A

C40H46N4O2 (614.3620576)

Gln His Leu Phe Gly

C29H42N8O7 (614.3176301999999)

Pleiomutinine

C40H46N4O2 (614.3620576)

LPI 19:0-d5_ISTD

C28H55O12P (614.343096)

LPI 19:0-d4

C28H55O12P (614.343096)

Phe His Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H42N12O5 (614.3400962)

Phe Arg His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H42N12O5 (614.3400962)

Phe Arg Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H42N12O5 (614.3400962)

Neomycin C

C23H46N6O13 (614.3122705999999)

C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

His Phe Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C27H42N12O5 (614.3400962)

His Arg Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C27H42N12O5 (614.3400962)

His Arg Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C27H42N12O5 (614.3400962)

Gln Arg Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C23H46N14O6 (614.3724576)

Arg Phe His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C27H42N12O5 (614.3400962)

Arg Phe Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H42N12O5 (614.3400962)

Arg His Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C27H42N12O5 (614.3400962)

Arg His Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C27H42N12O5 (614.3400962)

Arg Gln Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C23H46N14O6 (614.3724576)

Arg Arg Phe His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C27H42N12O5 (614.3400962)

Arg Arg His Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C27H42N12O5 (614.3400962)

Arg Arg Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C23H46N14O6 (614.3724576)

Arg Arg Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C23H46N14O6 (614.3724576)

ALLLW

Ala-Leu-Leu-Leu-Trp

C32H50N6O6 (614.379164)

LIVDR

Leu Ile Val Asp Arg

C27H50N8O8 (614.375142)

PEELK

Pro-Glu-Glu-Leu-Lys

C27H46N6O10 (614.3275256)

QLNLK

Gln Leu Asn Leu Lys

C27H50N8O8 (614.375142)

Harderoporphyrinogen

C35H42N4O6 (614.3104192000001)

PI(19:0/0:0)

1-nonadecanoyl-glycero-3-phospho-(1-myo-inositol)

C28H55O12P (614.343096)

PI(O-20:0/0:0)

1-eicosyl-glycero-3-phospho-(1-myo-inositol)

C29H59O11P (614.3794793999999)

Lycogaride F

1,2-(8R,9R-epoxy-octadec-13Z,15Z-dien-4,6-diynoyl)-sn-glycerol

C38H46O7 (614.3243365999999)

LPI 19:0

1-nonadecanoyl-glycero-3-phospho-(1-myo-inositol)

C28H55O12P (614.343096)

LPI O-20:0

1-eicosyl-glycero-3-phospho-(1-myo-inositol)

C29H59O11P (614.3794793999999)

Hellebrigenin-3-(12-hydroxy-laurate)

3beta,5beta,14beta-trihydroxy-19-oxo-bufa-20,22-dienolide-3beta-yl-(12-hydroxy-dodecanoate)

C36H54O8 (614.3818484)

ST 35:7;O9

2beta,3beta,11alpha,14alpha,20R-pentahydroxy-20,22-[(4-hydroxybenzylidene)bis(oxy)]-24-methyl-5beta-cholest-7-en-6-one

C35H50O9 (614.345465)

PHORBOL, 20-OXO-20-DEOXY 12-MYRISTATE 13-ACETATE, 4BETA

C36H54O8 (614.3818484)

Atorvastatin tert-Butyl Ester

C37H43FN2O5 (614.315584)

Carbenoxolone sodium

Carbenoxolone disodium

C34H48Na2O7 (614.3195258)

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C471 - Enzyme Inhibitor > C54678 - Hydroxysteroid Dehydrogenase Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents

N,N-DIOCTYL-3,4,9,10-PERYLENEDICARBOXIMIDE

C40H42N2O4 (614.3144412)

5-Aminopentyl O-6-deoxy-alpha-L-galactopyranosyl-(1-3)-O-[beta-D-galactopyranosyl-(1-4)]-2-(acetylamino)-2-deoxy-beta-D-glucopyranoside

C25H46N2O15 (614.2898046)

trimethyl-[(2S,3R,4S,5R)-1,2,4,5,6-pentakis(trimethylsilyloxy)hexan-3-yl]oxysilane

C24H62O6Si6 (614.3161832)

4-[[(1R)-2-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid

3-({2-[(2-{[(adamantan-2-yloxy)(hydroxy)methylidene]amino}-1-hydroxy-3-(1H-indol-3-yl)-2-methylpropylidene)amino]-1-phenylethyl}-C-hydroxycarbonimidoyl)propanoate

C35H42N4O6 (614.3104192000001)

4-[4-[(2R,5R)-5-[2-(Dibenzylamino)-2-oxoethyl]-2-heptyl-4-oxo-1,3-thiazolidin-3-yl]butyl]benzoic acid

C37H46N2O4S (614.3178116)

PA(8:0/PGJ2)

C31H51O10P (614.3219676)

PA(PGJ2/8:0)

C31H51O10P (614.3219676)

Acetyl Podocarpic Acid Anhydride

C38H46O7 (614.3243365999999)

Acetyl podocarpic acid anhydride is a potent, semisynthetic liver X receptor(LXR) agonist derived from extracts of the mayapple. Acetyl podocarpic acid anhydride has the potential to be useful for the prevention and research of atherosclerosis, especially in the context of low HDL levels[1].

3-(2,4-dimethoxyphenyl)-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

3-(2,4-dimethoxyphenyl)-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C35H42N4O6 (614.3104192000001)

3-(2,4-dimethoxyphenyl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

3-(2,4-dimethoxyphenyl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C35H42N4O6 (614.3104192000001)

3-(2,4-dimethoxyphenyl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

3-(2,4-dimethoxyphenyl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C35H42N4O6 (614.3104192000001)

3-(2,4-dimethoxyphenyl)-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

3-(2,4-dimethoxyphenyl)-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C35H42N4O6 (614.3104192000001)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

1-cyclohexyl-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea

C36H46N4O5 (614.3468025999999)

1-cyclohexyl-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea

C36H46N4O5 (614.3468025999999)

1-cyclohexyl-3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea

C36H46N4O5 (614.3468025999999)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C36H46N4O5 (614.3468025999999)

1-cyclohexyl-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea

C36H46N4O5 (614.3468025999999)

1-cyclohexyl-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea

C36H46N4O5 (614.3468025999999)

1-cyclohexyl-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea

C36H46N4O5 (614.3468025999999)

1-cyclohexyl-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea

C36H46N4O5 (614.3468025999999)

3-(2,4-dimethoxyphenyl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

3-(2,4-dimethoxyphenyl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C35H42N4O6 (614.3104192000001)

3-(2,4-dimethoxyphenyl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

3-(2,4-dimethoxyphenyl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C35H42N4O6 (614.3104192000001)

3-(2,4-dimethoxyphenyl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

3-(2,4-dimethoxyphenyl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea

C35H42N4O6 (614.3104192000001)

Rghgl

C32H54O11 (614.3665933999999)

5-aminopentyl beta-D-glucopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

C25H46N2O15 (614.2898046)

methyl (1R,4R,7S,14R,20R,21S,24E,25S,26S,38S,39R)-24-ethylidene-39-methyl-3,11,22,27-tetrazadodecacyclo[20.11.2.13,15.14,7.17,11.121,25.01,20.04,14.020,27.028,33.014,38.019,37]nonatriaconta-15(37),16,18,28,30,32-hexaene-26-carboxylate

methyl (1R,4R,7S,14R,20R,21S,24E,25S,26S,38S,39R)-24-ethylidene-39-methyl-3,11,22,27-tetrazadodecacyclo[20.11.2.13,15.14,7.17,11.121,25.01,20.04,14.020,27.028,33.014,38.019,37]nonatriaconta-15(37),16,18,28,30,32-hexaene-26-carboxylate

C40H46N4O2 (614.3620576)

[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] nonadecanoate

C28H55O12P (614.343096)

Smgdg O-11:0_8:0

C28H54O12S (614.3335804000001)

Smgdg O-10:0_9:0

C28H54O12S (614.3335804000001)

Smgdg O-17:0_2:0

C28H54O12S (614.3335804000001)

Smgdg O-13:0_6:0

C28H54O12S (614.3335804000001)

Smgdg O-14:0_5:0

C28H54O12S (614.3335804000001)

Smgdg O-16:0_3:0

C28H54O12S (614.3335804000001)

Smgdg O-8:0_11:0

C28H54O12S (614.3335804000001)

Smgdg O-12:0_7:0

C28H54O12S (614.3335804000001)

Smgdg O-15:0_4:0

C28H54O12S (614.3335804000001)

Smgdg O-9:0_10:0

C28H54O12S (614.3335804000001)

[(2R)-1,1,3,3-tetradeuterio-2-hydroxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] nonadecanoate

C28H55O12P (614.343096)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C31H51O10P (614.3219676)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C31H51O10P (614.3219676)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C31H51O10P (614.3219676)

[3-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-2-nonanoyloxypropyl] nonanoate

C27H51O13P (614.3067126)

[1-Heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] undecanoate

C27H51O13P (614.3067126)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C31H51O10P (614.3219676)

[1-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tetradecanoate

C27H51O13P (614.3067126)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C31H51O10P (614.3219676)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C31H51O10P (614.3219676)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] tridecanoate

C27H51O13P (614.3067126)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] pentadecanoate

C27H51O13P (614.3067126)

[1-Hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] dodecanoate

C27H51O13P (614.3067126)

[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] decanoate

C27H51O13P (614.3067126)

[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] hexadecanoate

C27H51O13P (614.3067126)

2-[[3-butanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3821592)

2-[[3-hexanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3821592)

2-[[3-acetyloxy-2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3821592)

2-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H57NO8P+ (614.3821592)

Framycetin

C23H46N6O13 (614.3122705999999)

A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials A tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B. R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AB - Antibiotics S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

1-nonadecanoyl-glycero-3-phospho-(1-myo-inositol)

C28H55O12P (614.343096)

1,2-(8R,9R-epoxy-octadec-13Z,15Z-dien-4,6-diynoyl)-sn-glycerol

C38H46O7 (614.3243365999999)

1-eicosyl-glycero-3-phospho-(1-myo-inositol)

C29H59O11P (614.3794793999999)

Toxiferine I

C40H46N4O2 (614.3620576)

DGGA 22:3;O

C31H50O12 (614.3302100000001)

DGGA 23:2

C32H54O11 (614.3665933999999)

PA O-29:5;O2

C32H55O9P (614.358351)

PA P-16:0/13:4;O2

C32H55O9P (614.358351)

PA P-16:1/13:3;O2

C32H55O9P (614.358351)

PA P-20:0/9:4;O2

C32H55O9P (614.358351)

PA 16:1/13:3;O

C32H55O9P (614.358351)

PA 18:2/11:2;O

C32H55O9P (614.358351)

PA 20:2/8:3;O2

C31H51O10P (614.3219676)

PA 20:3/7:3;O3

C30H47O11P (614.2855841999999)

PA 20:3/8:2;O2

C31H51O10P (614.3219676)

PA 20:3/9:1;O

C32H55O9P (614.358351)

PA 20:4/7:2;O3

C30H47O11P (614.2855841999999)

PA 20:4/8:1;O2

C31H51O10P (614.3219676)

PA 22:1/7:3;O

C32H55O9P (614.358351)

PA 27:6;O3

C30H47O11P (614.2855841999999)

PA 28:5;O2

C31H51O10P (614.3219676)

PA 29:4;O

C32H55O9P (614.358351)

LPG 26:5

C32H55O9P (614.358351)

PG O-25:6;O

C31H51O10P (614.3219676)

PG P-18:1/7:4;O

C31H51O10P (614.3219676)

PG 18:4/6:2;O

C30H47O11P (614.2855841999999)

PG 20:5/4:1;O

C30H47O11P (614.2855841999999)

PG 24:6;O

C30H47O11P (614.2855841999999)

LPI 18:1;O

C27H51O13P (614.3067126)

PI 14:0/4:0

C27H51O13P (614.3067126)

PI 16:0/2:0

C27H51O13P (614.3067126)

PI 18:0

C27H51O13P (614.3067126)

PI 2:0_16:0

C27H51O13P (614.3067126)

PEth 27:4;O

C32H55O9P (614.358351)

PM 28:4;O

C32H55O9P (614.358351)

ST 24:2;O7;GlcA

C30H46O13 (614.2938266)

ST 25:1;O6;GlcA

C31H50O12 (614.3302100000001)

ST 26:0;O5;GlcA

C32H54O11 (614.3665933999999)

ST 28:6;O4;GlcA

C34H46O10 (614.3090816)

ST 29:5;O3;GlcA

C35H50O9 (614.345465)

ST 24:3;O8;Hex

C30H46O13 (614.2938266)

ST 25:2;O7;Hex

C31H50O12 (614.3302100000001)

ST 26:1;O6;Hex

C32H54O11 (614.3665933999999)

ST 28:7;O5;Hex

C34H46O10 (614.3090816)

ST 29:6;O4;Hex

C35H50O9 (614.345465)

(1r,2s,4s,6r,7s,10s,11r,18r)-7,11-dimethyl-14-oxo-6-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-18-yl acetate

(1r,2s,4s,6r,7s,10s,11r,18r)-7,11-dimethyl-14-oxo-6-[(1r)-1-[(1s,3r,5r)-5,6,6-trimethyl-1-[2-(methylsulfanyl)-2-oxoethyl]-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadeca-12,15-dien-18-yl acetate

C34H46O8S (614.2913236)

(2e)-4-[(1s,2s,13s,15r)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,8-dihydroxy-17,17-dimethyl-5-(3-methylbut-2-en-1-yl)-10,14-dioxo-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraen-15-yl]-2-methylbut-2-enal

(2e)-4-[(1s,2s,13s,15r)-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,8-dihydroxy-17,17-dimethyl-5-(3-methylbut-2-en-1-yl)-10,14-dioxo-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraen-15-yl]-2-methylbut-2-enal

C38H46O7 (614.3243365999999)

(4ar,5s,6as,6br,8ar,9r,10s,12ar,12br,14bs)-5,10-bis(acetyloxy)-9-[(acetyloxy)methyl]-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H54O8 (614.3818484)

5-(acetyloxy)-6-[3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C36H54O8 (614.3818484)

2-[(2e)-1-{[(1s)-1-carboxy-2-(1h-indol-3-yl)ethyl]-c-hydroxycarbonimidoyl}-10-oxoheptadec-2-en-1-yl]-2-hydroxybutanedioic acid

C33H46N2O9 (614.3203146)

15-(7-hydroxy-6-methylheptan-2-yl)-2,16-dimethyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadecane-9,11,13,14-tetrol

C32H54O11 (614.3665933999999)

(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (2e,4e)-3-methyl-5-[(1r,2r,3r)-1,2,3-trihydroxy-2,6,6-trimethylcyclohexyl]penta-2,4-dienoate

(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (2e,4e)-3-methyl-5-[(1r,2r,3r)-1,2,3-trihydroxy-2,6,6-trimethylcyclohexyl]penta-2,4-dienoate

C30H46O13 (614.2938266)

n-[2-({[(1r,2r,3r,4s,5s,6s,8r,9s,10r,13s,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]ethanimidic acid

n-[2-({[(1r,2r,3r,4s,5s,6s,8r,9s,10r,13s,16s,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]ethanimidic acid

C33H46N2O9 (614.3203146)

3-[5,8,11-trihydroxy-3-(hydroxymethyl)-6-(1h-indole-3-carbonyl)-12-methyl-13-(octan-2-yl)-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-9-yl]propanoic acid

C31H42N4O9 (614.2951642)

{6-[7-(acetyloxy)-1-hydroxy-3a,6,6,9a,11a-pentamethyl-2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dihydroxy-2-methylheptyl}oxysulfonic acid

C32H54O9S (614.3488354)

(1s,2r,4r,12s,18r)-14,14,18-trimethyl-5-[(1r,12r,15s,17s)-1,14,14-trimethyl-19-oxo-9,13-diazapentacyclo[13.2.2.0²,¹⁰.0³,⁸.0¹²,¹⁷]nonadeca-2(10),3,5,7-tetraen-7-yl]-5,13-diazahexacyclo[13.3.1.0²,¹³.0⁴,¹².0⁴,¹⁸.0⁶,¹¹]nonadeca-6,8,10-trien-16-one

(1s,2r,4r,12s,18r)-14,14,18-trimethyl-5-[(1r,12r,15s,17s)-1,14,14-trimethyl-19-oxo-9,13-diazapentacyclo[13.2.2.0²,¹⁰.0³,⁸.0¹²,¹⁷]nonadeca-2(10),3,5,7-tetraen-7-yl]-5,13-diazahexacyclo[13.3.1.0²,¹³.0⁴,¹².0⁴,¹⁸.0⁶,¹¹]nonadeca-6,8,10-trien-16-one

C40H46N4O2 (614.3620576)

2,4a-dimethyl (2s,4ar,6as,6br,8as,10r,11s,12ar,12bs,14bs)-10,11-bis(acetyloxy)-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylate

C36H54O8 (614.3818484)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5r,6r)-6-{[(1s,3r,4s,4ar,8ar)-4-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5r,6r)-6-{[(1s,3r,4s,4ar,8ar)-4-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalen-1-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O11 (614.3665933999999)

n-[2-({[(1r,2r,3r,4s,5s,6s,8r,9s,10r,16s,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]ethanimidic acid

n-[2-({[(1r,2r,3r,4s,5s,6s,8r,9s,10r,16s,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]ethanimidic acid

C33H46N2O9 (614.3203146)

(1r,2r,6s,7s,8r,10s,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-[(1e,3e)-undeca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

(1r,2r,6s,7s,8r,10s,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-16-(prop-1-en-2-yl)-14-[(1e,3e)-undeca-1,3-dien-1-yl]-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

C34H46O10 (614.3090816)

(1r,3r,4s,5r,7s,8s,9r,10e,12s,13s,14s)-4,8-bis(acetyloxy)-3,6,6,10,14-pentamethyl-9-{[(2e)-2-methylbut-2-enoyl]oxy}-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-13-yl (2e)-2-methylbut-2-enoate

(1r,3r,4s,5r,7s,8s,9r,10e,12s,13s,14s)-4,8-bis(acetyloxy)-3,6,6,10,14-pentamethyl-9-{[(2e)-2-methylbut-2-enoyl]oxy}-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-13-yl (2e)-2-methylbut-2-enoate

C34H46O10 (614.3090816)

(2e,5s,6s)-6-[(1r,3s,3ar,5ar,7s,9as,11ar)-3,7-bis(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

C36H54O8 (614.3818484)

(1s,4s,5s,8r,9r,12r,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

(1s,4s,5s,8r,9r,12r,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C36H54O8 (614.3818484)

(1r,4s,5s,8r,9r,12s,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

(1r,4s,5s,8r,9r,12s,13s,16s)-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C36H54O8 (614.3818484)

(1s,2r,4r,12s,18r)-14,14,18-trimethyl-10-[(1s,2r,4r,15s,18r)-14,14,18-trimethyl-16-oxo-5,13-diazahexacyclo[13.3.1.0²,¹³.0⁴,¹².0⁴,¹⁸.0⁶,¹¹]nonadeca-6,8,10-trien-5-yl]-5,13-diazahexacyclo[13.3.1.0²,¹³.0⁴,¹².0⁴,¹⁸.0⁶,¹¹]nonadeca-6,8,10-trien-16-one

(1s,2r,4r,12s,18r)-14,14,18-trimethyl-10-[(1s,2r,4r,15s,18r)-14,14,18-trimethyl-16-oxo-5,13-diazahexacyclo[13.3.1.0²,¹³.0⁴,¹².0⁴,¹⁸.0⁶,¹¹]nonadeca-6,8,10-trien-5-yl]-5,13-diazahexacyclo[13.3.1.0²,¹³.0⁴,¹².0⁴,¹⁸.0⁶,¹¹]nonadeca-6,8,10-trien-16-one

C40H46N4O2 (614.3620576)

(9-hydroxy-5a,10b-dimethyl-3-{1,6,7,11,11-pentamethyl-2-oxatricyclo[8.4.0.0³,⁷]tetradecan-6-yl}-1h,2h,3h,3ah,4h,5h,10h,10ah-cyclopenta[a]fluoren-6-yl)oxidanesulfonic acid

C36H54O6S (614.3640904)

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-4-(acetyloxy)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-4-(acetyloxy)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C33H46N2O9 (614.3203146)

(4as,5r,8ar)-5-{[(1r,4as,8as)-5,5,8a-trimethyl-2-methylidene-3-oxo-hexahydronaphthalen-1-yl]methyl}-4a-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)-2-methoxy-6-methyl-8,8a-dihydro-5h-naphthalene-1,4-dione

C37H42O8 (614.2879532000001)